CORC

在结果中检索

CORC

浏览/检索结果: 共320条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Simulation Study on Scaler Mode in LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Huang, Zhicheng;  Huang, Daihui;  Zhou, Xunxiu;  Zhao, Jing;  He, Huihai
收藏  |  浏览/下载：19/0  |  提交时间：2023/01/16
Measurement of very-high-energy diffuse gamma-ray emission from Galactic plane with LHAASO-KM2A 会议论文
Virtual, Berlin, Germany, 2021-07-12
作者:  Zhang, Rui;  Zhao, Shiping;  Zhang, Yi;  Yuan, Qiang;  Cao, Zhen
收藏  |  浏览/下载：19/0  |  提交时间：2023/01/23
The Security Assessment on Programmable Logic Controller based on Attack Tree Model and FAHP 会议论文
Shenyang, China, July 12, 2019 - July 14, 2019
作者:  Feng, Tao;  Shi, Yanxia;  Gong, Renbin;  Zhao, Qianchuan
收藏  |  浏览/下载：11/0  |  提交时间：2020/11/15
Risk Factors Related to the Development of Post Stroke Cognitive Impairment in Shanghai Stroke Population 会议论文
作者:  Dong Yi;  Cui Mei;  Fang Min;  Gong Li;  Wang Xiuzhe
收藏  |  浏览/下载：59/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：48/0  |  提交时间：2019/12/05
Classification of Schizophrenia Patients and Healthy Controls Using ICA of Complex-Valued fMRI Data and Convolutional Neural Networks 会议论文
16th International Symposium on Neural Networks, ISNN 2019, Moscow, Russia, 2019-07-10
作者:  Qiu, Yue;  Lin, Qiu-Hua;  Kuang, Li-Dan;  Zhao, Wen-Da;  Gong, Xiao-Feng
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：39/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：40/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：33/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace